Common Contracts
8 similar Underwriting Agreement contracts by Hospira Inc, Agco Corp /De, Aviva PLC, others
HOSPIRA, INC. $350,000,000 5.200% Notes Due 2020 $350,000,000 5.800% Notes Due 2023 UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2013 • Hospira Inc • Pharmaceutical preparations • New York
The opinion of Mayer Brown LLP, outside counsel for the Company, to be delivered pursuant to Section 5(c) of Underwriting Agreement, shall be to the effect that:
AVIVA PLC $400,000,000 8.25% CAPITAL SECURITIES DUE 2041 UNDERWRITING AGREEMENT November 17, 2011Underwriting Agreement • November 22nd, 2011 • Aviva PLC • Life insurance • New York
Aviva plc, a public limited company incorporated under the laws of England and Wales (the “Company”), proposes to issue and sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you are acting as joint book-running managers, the principal amount of its debt securities identified in Schedule II hereto (the “Initial Securities”), to be issued under the subordinated indenture to be dated as of the Closing Date (as defined below) (the “Subordinated Indenture”), between the Company and Law Debenture Trust Company of New York (the “Trustee”), as supplemented by the supplemental indenture to be dated as of the Closing Date (the “Supplemental Indenture” and together with the Subordinated Indenture the “Indenture”) between the Company and the Trustee, and to grant to the Underwriters the option to purchase all or any part of the additional securities identified in Schedule II hereto (the “Additional Securities”, and together with the Initial Securities, the
HOSPIRA, INC. $500,000,000 5.600% Notes Due 2040 UNDERWRITING AGREEMENTUnderwriting Agreement • September 10th, 2010 • Hospira Inc • Pharmaceutical preparations • New York
The opinion of Mayer Brown LLP, outside counsel for the Company, to be delivered pursuant to Section 5(c) of Underwriting Agreement, shall be to the effect that:
HOSPIRA, INC. $250,000,000 6.400% Notes Due 2015 UNDERWRITING AGREEMENTUnderwriting Agreement • May 7th, 2009 • Hospira Inc • Pharmaceutical preparations • New York
BORGWARNER INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 9th, 2009 • Borgwarner Inc • Motor vehicle parts & accessories • New York
BorgWarner Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule II hereto (the “Underwriters”), for whom you are acting as managers (the “Managers”) and for whom Morgan Stanley & Co. Incorporated and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as representatives (the “Representatives”), the principal amount of its 3.50% Convertible Senior Notes due 2012 set forth in Schedule I hereto (the “Firm Securities”), to be issued under the indenture specified in Schedule I hereto (the “Indenture”) between the Company and the Trustee identified in such Schedule (the “Trustee”). The Company also proposes to issue and sell to the several Underwriters an additional principal amount of its 3.50% Convertible Senior Notes due 2012 not exceeding the principal amount set forth in Schedule I hereto (the "Additional Securities”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Unde
UST INC. 5.75% Senior Notes due 2018 UNDERWRITING AGREEMENTUnderwriting Agreement • February 29th, 2008 • Ust Inc • Tobacco products • New York
AGCO CORPORATION 1.25% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2036 UNDERWRITING AGREEMENTUnderwriting Agreement • December 4th, 2006 • Agco Corp /De • Farm machinery & equipment • New York
SABRE HOLDINGS CORPORATION $400,000,000 6.350% Senior Notes due 2016 UNDERWRITING AGREEMENTUnderwriting Agreement • March 10th, 2006 • Sabre Holdings Corp • Services-computer processing & data preparation • New York
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-866-718-1649 (institutional investors) or 1-800-584-6837 (retail investors).
